Application of Non-Vasopressor Adjunctive Therapies and Support Devices in Refractory Shock Management

Sunday, February 23, 2025

4:35pm – 4:50pm Eastern Time

Location: Valencia Ballroom/415A

Carlos Alviar, MD (he/him/his)

NYU Grossman School of Medicine

Disclosure(s): Abbott Cardiovascular: Consultant (Terminated, January 1, 2024); Abiomed: Consultant (Terminated, January 1, 2024); Baxter Healthcare: Grant/Research Support (Ongoing); Zoll Medical: Consultant (Ongoing)

Disclosure(s):

Carlos Alviar Restrepo, MD: Abbott Cardiovascular: Consultant (Terminated, January 1, 2024); Abiomed: Consultant (Terminated, January 1, 2024); Baxter Healthcare: Grant/Research Support (Ongoing); Zoll Medical: Consultant (Ongoing)

Adjunctive pharmacotherapeutic agents as well as support devices as it relates to second and third line management for refractory shock will be discussed. Literature surrounding the role in therapy of these salvage therapies will be explored to provide attendees with the knowledge to appropriately select and utilize these therapies in their specific patients, as appropriate.